Monoclonal gammopathy of neurological significance (MGNS)

Clinical trials for Monoclonal gammopathy of neurological significance (MGNS) explained in plain language.

Never miss a new study

Get alerted when new Monoclonal gammopathy of neurological significance (MGNS) trials appear

Sign up with your email to follow new studies for Monoclonal gammopathy of neurological significance (MGNS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Banking blood and bone marrow to decode plasma cell disorders

Knowledge-focused Recruiting now

Researchers at Peking University First Hospital are building a prospective cohort of 2,000 people with plasma cell disorders, including multiple myeloma, amyloidosis, and related conditions. Participants give blood, bone marrow, and urine samples before and after treatment, and t…

Matched conditions: MONOCLONAL GAMMOPATHY OF NEUROLOGICAL SIGNIFICANCE (MGNS)

Sponsor: Peking University First Hospital • Aim: Knowledge-focused

Last updated Sep 18, 2026 00:00 UTC

Monoclonal gammopathy of neurological significance (MGNS)

Get alerted when new Monoclonal gammopathy of neurological significance (MGNS) trials appear

Banking blood and bone marrow to decode plasma cell disorders